Journal article
Utilization and Outcomes of Temporary Percutaneous Right Ventricular Assist Devices in Cardiogenic Shock
ASAIO journal (1992), v 71(5)
14 Nov 2024
PMID: 40310015
Featured in Collection : UN Sustainable Development Goals @ Drexel
Abstract
Acute right ventricular failure (RVF) is a common finding in cardiogenic shock (CS), yet the optimal method of supporting the failing RV remains unclear. This study aimed to describe CS patients receiving percutaneous right ventricular assist devices (pRVADs) using the multicenter Cardiogenic Shock Working Group (CSWG) registry. Among 6,201 patients with CS, 152 (2.4%) received pRVADs, with ProtekDuo and Impella RP being used in 71% and 29% of cases, respectively. The average age of this group was 58.5 years, with a higher proportion of men (66.4%). Heart failure–associated CS (HF-CS) was observed in 48% of patients, while myocardial infarction–associated CS (MI-CS) was seen in 27% (HF-CS versus MI-CS: 52.8% vs. 21.3% for ProtekDuo; 36.4% vs. 40.9% for Impella RP; p = 0.01). The overall in-hospital mortality rate was 54.6%, bleeding complications were more prevalent among ProtekDuo recipients (64.8% vs. 43.2%, p = 0.008), whereas Impella RP recipients had shorter hospital stays (20.4 ± 18.7 vs. 41.9 ± 31.5 days, p < 0.001). ProtekDuo was more commonly used in patients with HF-CS and was associated with higher rates of bleeding and longer hospital stays compared with Impella RP, although overall mortality was similar. Further investigation is required to determine the ideal timing and clinical conditions warranting pRVAD deployment in CS.
Metrics
25 Record Views
Details
- Title
- Utilization and Outcomes of Temporary Percutaneous Right Ventricular Assist Devices in Cardiogenic Shock
- Creators
- Kevin John John - Tufts Medical CenterJaime Hernandez-Montfort - Baylor Scott & White HealthManreet K. Kanwar - Allegheny Health NetworkSong Li - Institute for Advanced Cardiac Care, Medical City Healthcare, Dallas, TexasArthur Reshad Garan - Beth Israel Deaconess Medical CenterShashank S. Sinha - Inova Fairfax HospitalJacob Abraham - Providence CollegeSaraschandra Vallabhajosyula - Brown UniversityBorui Li - Tufts Medical CenterQiuyue Kong - Tufts Medical CenterPaavni Sangal - Tufts Medical CenterDaniel Burkhoff - Cardiovascular Research FoundationNavin K. Kapur - Tufts Medical Centeron behalf of the Cardiogenic Shock Working Group
- Publication Details
- ASAIO journal (1992), v 71(5)
- Publisher
- Lippincott; PHILADELPHIA
- Number of pages
- 8
- Grant note
- AbiomedBoston ScientificAbbott LaboratoriesGetingeLivaNova
This work was supported by institutional grants from Abiomed, Boston Scientific and Abbott Laboratories, Getinge, and LivaNova to Tufts Medical Center. Sponsors had no input in collection, analysis, or interpretation of the data nor in the preparation, review, or approval of the manuscript.
- Resource Type
- Journal article
- Language
- English
- Academic Unit
- Cardiology
- Web of Science ID
- WOS:001479671200012
- Scopus ID
- 2-s2.0-85210768949
- Other Identifier
- 991021961002104721
UN Sustainable Development Goals (SDGs)
This publication has contributed to the advancement of the following goals:
InCites Highlights
Data related to this publication, from InCites Benchmarking & Analytics tool:
- Collaboration types
- Domestic collaboration
- Web of Science research areas
- Engineering, Biomedical
- Transplantation